Ultime notizie per AB Science (OTC:ABSCF) Azioni

AB Science is a France-based pharmaceutical company specialized in the research, discovery, development, and marketing of protein kinase inhibitors. It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine.

AB SCIENCE PARIS ORD by AB Science, Paris

Comments

AB Science

Notizie

Ultime notizie per AB Science (OTC:ABSCF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO